Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pleckstrin homology domain-containing family J member 1 (PLEKHJ1) is a protein-coding gene found in humans and other species, encoding a protein that contains a pleckstrin homology domain[1][2]. This protein is predicted to participate in cellular processes such as endosome organization, receptor recycling, and retrograde transport from endosomes to the Golgi apparatus[2][3]. It is primarily localized to cellular compartments such as the Golgi apparatus, cytosol, cytoplasmic vesicles, early endosome, and recycling endosome[2][3]. PLEKHJ1 has been described in fusion events with TCF3 in cancer genome data, although its independent role in disease or as a therapeutic target is not well established[5]. There are no known drugs or biomarkers clinically validated for this gene, and no established safety concerns associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain-containing family J member 1 (PLEKHJ1).